180 related articles for article (PubMed ID: 33441290)
21. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3 proteins and reverse transcription.
Aguiar RS; Peterlin BM
Virus Res; 2008 Jun; 134(1-2):74-85. PubMed ID: 18262674
[TBL] [Abstract][Full Text] [Related]
23. DNA deamination in immunity: AID in the context of its APOBEC relatives.
Conticello SG; Langlois MA; Yang Z; Neuberger MS
Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
[TBL] [Abstract][Full Text] [Related]
24. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
25. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
Romani B; Engelbrecht S; Glashoff RH
Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3s: DNA-editing human cytidine deaminases.
Silvas TV; Schiffer CA
Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
[TBL] [Abstract][Full Text] [Related]
28. Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure.
McDaniel YZ; Wang D; Love RP; Adolph MB; Mohammadzadeh N; Chelico L; Mansky LM
Nucleic Acids Res; 2020 Feb; 48(3):1353-1371. PubMed ID: 31943071
[TBL] [Abstract][Full Text] [Related]
29. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
[TBL] [Abstract][Full Text] [Related]
31. Editing at the crossroad of innate and adaptive immunity.
Turelli P; Trono D
Science; 2005 Feb; 307(5712):1061-5. PubMed ID: 15718460
[TBL] [Abstract][Full Text] [Related]
32. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs regulate APOBEC gene expression.
Cao W; Wu W
Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
[TBL] [Abstract][Full Text] [Related]
34. New World feline APOBEC3 potently controls inter-genus lentiviral transmission.
Konno Y; Nagaoka S; Kimura I; Yamamoto K; Kagawa Y; Kumata R; Aso H; Ueda MT; Nakagawa S; Kobayashi T; Koyanagi Y; Sato K
Retrovirology; 2018 Apr; 15(1):31. PubMed ID: 29636069
[TBL] [Abstract][Full Text] [Related]
35. [The innate antiretroviral defense of human cells, based on the DNA editing].
Pupecka M; Pacak A
Postepy Biochem; 2006; 52(3):247-52. PubMed ID: 17201059
[TBL] [Abstract][Full Text] [Related]
36. Mice deficient in APOBEC2 and APOBEC3.
Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3A damages the cellular genome during DNA replication.
Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
[TBL] [Abstract][Full Text] [Related]
38. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
39. Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.
McDonnell MM; Karvonen SC; Gaba A; Flath B; Chelico L; Emerman M
PLoS Pathog; 2021 Jun; 17(6):e1009523. PubMed ID: 34170969
[TBL] [Abstract][Full Text] [Related]
40. The inhibition of hepatitis B virus by APOBEC cytidine deaminases.
Janahi EM; McGarvey MJ
J Viral Hepat; 2013 Dec; 20(12):821-8. PubMed ID: 24304451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
